Review of vascularized bone marrow transplantation: Current status and future clinical applications

Microsurgery

Volumn 27, Issue 4, 2007, Pages 348-353

  Gordon, Chad R ^a   Tai, Chau Y ^a   Suzuki, Hidetoshi ^b   Strande, Louise F ^a   Ramsamooj, Rajendra ^c   Matthews, Martha S ^a   Black, Kirby S ^d   Hewitt, Charles W ^a  

^a Department of Anesthesiology   (United States)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KENNESAW STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; MICROSURGERY; PRIORITY JOURNAL; SURGICAL APPROACH; VASCULAR SURGERY; VASCULARIZED BONE MARROW TRANSPLANTATION;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; CHIMERISM; GRAFT VS HOST DISEASE; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; MICE; MODELS, ANIMAL; STEM CELL TRANSPLANTATION; TRANSPLANTATION, ISOGENEIC;

EID: 34250172441     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20367     Document Type: Conference Paper

References (52)

1. Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patient receiving radiation and chemotherapy. N Engl J Med 1957;257:491-496.
2. Jacobson LO, Simmons EL, Marks EK, Gaston EO, Robson MJ, Eldredge JH. The role of the spleen in radiation injury and recovery. J Lab Clin Med 1950;35:746-770.
3. Lorenz E, Uphoff D, Reid TR, Shelton E. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951;12:197-201.
4. Appelbaum FR, Herzig GP, Ziegler JL, Graw RG, Levine AS, Deisseroth AB. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978;52:85-95.
5. Shapiro RI, Cerra FB. A model for reimplantation and transplantation of a complex organ: The rat hind limb. J Surg Res 1978;29:229-231.
6. Hewitt CW, Black KS, Dowdy SF, Gonzalez GA, Achauer BM, Martin DC, Furnas DW, Howard EB. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation 1986;41:39-43.
7. Muramatsu K, Kurokawa Y, Ihara K, You-Xin S, Kawai S. Donor cell engraftment in recipient lymphoid tissues after rat limb allograft. J Surg Res 2005;124:38-44.
8. Janczweska S, Ziolkowska A, Durlik M, Olszewski WL, Lukomska B. Fast lymphoid reconstitution after vascularized bone marrow transplantation in lethally irradiated rats. Transplantation 1999;68:201-209.
9. Lassmann H. Stem cell and progenitor cell transplantation in multiple sclerosis: The discrepancy between neurobiological attraction and clinical feasibility. J Neurol Sci 2005;233:83-86.
10. Joseph NM, Mukouyama YS, Mosher JT, Jaegle M, Crene SA, Dormand EL, Lee KF, Meijer D, Anderson DJ, Morrison SJ. Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells. Development 2004;131:5599-5612.
11. Passier R, Mummery C. Cardiomyocyte differentiation from embryonic and adult stem cells. Curr Opin Biotechnol 2005;16:498-502.
12. Morasso MI, Tomic-Canic M. Epidermal stem cells: The cradle of epidermal determination, differentiation and wound healing. Biol Cell 2005;97:173-183.
13. Wang Y, Beltlower RM, Dong YF, Schwarz EM, O'Keefe RJ. Drissi H. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. J Bone Miner Res 2005;20:1624-1636.
14. Raghunath J, Salacinski HJ, Sales KM, Butler PE, Seifalian AM. Advancing cartilage tissue engineering: The application of stem cell technology. Curr Opin Biotechnol 2005;16:503-509.
15. Kume S, Kato S, Yamagishi S, Inagaki Y, Ueda S, Arima N, Okawa T, Kojiro M, Nagata K. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res 2005;20: 1647-1658.
16. Suzuki H, Patel N, Matthews MS, DelRossi AJ, Doolin EJ, Hewitt CW. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow. J Surg Res 2000; 89:176-183.
17. Tai CY, France MA, Strande LF, Eydelman R, Sheng X, Matthews MS, Dalsey R, Hewitt CW. An extraperitoneal isolated vascularized bone marrow transplant model in the rat. Transplantation 2003;75: 1591-1593.
18. Tai C, Armour RP, Reid L, Matthews MS, Dalsey R, Hewitt CW. Cell volume in a novel isolated vascularized bone marrow transplant model. FASEB J 2002;16:A602.
19. Tai CY, Strande LF, Lounev V, Hewitt CW. Vascularized bone marrow transplantation: A new surgical approach to bone marrow transplantation induces immunological tolerance. Am J Transplant 2005;5(Suppl):366.
20. Tai CY, Strande LF, Eydelman R, Shang X, VanTran JL, Matthews MS, Hewitt CW. Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant. Transplantation 2004;77:316-319.
21. Tai CY, Dalsania C, Reid L, Suzuki H, Hewitt CW. Morphometric and immunohistochemical findings in the isolated vascularized bone marrow transplantation rejection model. Lab Invest 2002;82: 266A.
22. Sakamoto K, Arita S, Sakamaki T, Yamada H, Kusume K, Yoshida T, Okazaki Y, Yamada K, Gunji Y, Shimada H, Ochiai T, Kashiwakasa H, Yokoyama T. Better clinical outcome in renal transplant recipients with peripheral blood microchimerism. Transplant Proc 2000;32:1793-1794.
23. Yano Y, Hara M, Miyahara T, Shibata K, Onitsuka T, Nawa Y, Li XK, Suzuki S, Anemiya H, Kimusa H. Microchimeric cells from the peripheral blood associated with cardiac grafts are bone marrow derived, long-lived and maintain acquired tolerance to minor histocompatibility antigen H-Y. Transplantation 2001;71:1456-1462.
24. Hisanaga M, Schlitt HJ, Hundrieser J, Wonigeit K, Nakajima Y, Kanehiro H, Nakano H, Pichlmayr R. Frequency and clinical correlations of allogeneic microchimerism after heart, liver, and lung transplantation. Transplant Proc 1997;29:1215-1217.
25. Elwood ET, Larsen CP, Maurer DH, Routenberg KL, Neylan JF, Whelchel JD, O'brien DP, Pearson TC. Microchimerism and rejection in clinical transplantation. Lancet 1997;349:1336-1337.
26. Gamier JL, Touraine JL, Gebuhrer L. No detectable microchimerism in long-term tolerant recipients of living-donor kidneys. Transplant Proc 1997;29:1181.
27. Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, Shaffer J, Sayegh MH, Sykes M. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000;6:464-469.
28. Eto M, Kong YY, Uozumi J, Naito S, Nomoto K. Importance of intrathymic mixed chimerism for the maintenance of skin allograft tolerance across fully allogeneic antigens in mice. Immunology 1999;96: 440-446.
29. Kawaharada N, Shears LL II, Li S, Pham SM. Mixed hematopoietic chimerism prevents allograft vasculopathy. J Heart Lung Transplant 1999;18:532-541.
30. Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA, Greiner DL. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000;95:2175-2182.
31. Bingaman AW, Waitze SY, Alexander DZ, Cho HR, Lin A, Tucker-Burden C, Cowan SR, Pearson TC, Larsen CP. Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning. Transplantation 2000;69:2491-2496.
32. Muramatsu K, Kurokawa Y, Ihara K, You-Xin S, Kawai S. Donor cell engraftment in recipient lymphoid tissues after rat limb allograft. J Surg Res 2005;124:38-44.
33. Durlik M, Lukomska B, Religa P, Zolkowska H, Namyslowski A, Janczewska S, Cybulska E, Soin J, Gaciong Z, Olszewski WL. Tolerance induction following allogeneic vascularized bone marrow transplantation: The possible role of microchimerism. Transpl Int 1998; 11(Suppl 1):S299-S302.
34. Klimczak A, Agaoglu G, Camevale KA, Siemionow M. Applications of a bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier, Part 2. Ann Plast Surg 2006;57:422-430.
35. Balon J, Halaburda K, Bieniaszweska M, Reichert M, Bieniaszewski L, Piekarska A, Pawlowski R, Hellmann A. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transplant 2005;35: 1083-1088.
36. Prentice HG, Blacklock HA, Janossy G, Gilmore MJ, Price-Jones L, Tidman N, Trejdosiewicz LK, Skeggs DB, Panjwani D, Ball S. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984;1:472-476.
37. Ho VT, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001;98:3192-3204.
38. Ramsamooj R, Llull R, Patel MP, Beko KR II, Black KS, Hewitt CW. Mechanisms of alloimmune tolerance associated with mixed chimerism induced by vascularized bone marrow transplants. Cell Transplant 2002;11:683-693.
39. Hewitt CW, Ramsamooj R, Patel MP, Yazdi B, Achauer BM, Black KS. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation 1990;50:766-772.
40. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 2003;75:389-397.
41. Chung NG, Jeong DC, Park SJ, Choi BO, Cho B, Kim HK, Chun CS, Won JH, Han CW. Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation. Int J Hematol 2004;80:370-376.
42. Ishida T, Inaba M, Hisha H, Sugiura K, Adachi Y, Nagata N, Ogawa R, Good RA, Ikehara S. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune disease in MRL/MP-lpr/lpr mice by transplantation bone marrow plus bones (stromal cells) from the same donors. J Immunol 1994;152:3119-3127.
43. Jantunen E, Myllykangas-Luosujarvi R. Stem cell transplantation for severe autoimmune diseases: Current status and future perspectives. Bone Marrow Transplant 2000;116:721-727.
44. Van Bekkum DW. Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol 2000;20:10-16.
45. Sterman HR, Strauch B. Microvascular free transfer of the medial wall of the Iliac Crest on the DCIA for mandibular reconstruction. In: Strauch B, Vasconez LO, Hall-Findlay EJ, editors. Grabb's Encyclopedia of Flaps, 2nd ed. Philadelphia: Lippincott-Raven; 1998. p 753.
46. Thomas J, Carver M, Cunningham P, Park K, Gonder J, Thomas F. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. I. In vivo parameters and immunohistologic evidence suggesting mechanisms. Transplantation 1987;43:332-338.
47. Ricordi C, Murase N, Rastellini C, Behboo R, Demetris AJ, Starzl TE. Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation. Cell Transplant 1996;5:53-55.
48. Zeevi A, Pavlick M, Banas R, Bentlejewski C, Spichty K, Rao AS, Fontes P, Iyengar A, Shapiro R, Dodson F, Jordan M, Pham S, Keenan R, Griffith B, Corry R, Egidi F, Fung JJ, Starzl TE. Three years of follow-up of bone marrow-augmented organ transplant recipients: The impact on donor-specific immune modulation. Transplant Proc 1997; 29:1205-1206.
49. Shapiro R, Rao AS, Fontes P, Zeevi A, Jordan M, Scantlebury VP, Vivas C, Gritsch HA, Corry RJ, Egidi F, Starzl TE. Combined simultaneous kidney/bone marrow transplantation. Transplantation 1995;60: 1421-1425.
50. Rolles K, Burroughs AK, Davidson BR, Karatapanis S, Prentice HG, Hamon MD. Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet 1994;343:263-265.
51. Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Hoppe RT, Bloch DA, Blume KG, Negrin RS, Strober S. Protective conditioning for acute graft-versus-host disease. N Engl J Med 2005;353: 1321-1331.
52. Kawai T, Sogawa H, Boskovic S, Abrahamian G, Smith RN, Wee SL, Andrews D, Nazazdin O, Kayama I, Sykes M, Winn HJ, Colvin RB, Sachs DH, Cosimi AB. CD145 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 2004;4:1391-1398.